408 related articles for article (PubMed ID: 18019829)
1. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.
Uner M; Yener G
Int J Nanomedicine; 2007; 2(3):289-300. PubMed ID: 18019829
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.
Müller RH; Radtke M; Wissing SA
Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S131-55. PubMed ID: 12460720
[TBL] [Abstract][Full Text] [Related]
3. The use of solid lipid nanoparticles for sustained drug release.
Attama AA; Umeyor CE
Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
[TBL] [Abstract][Full Text] [Related]
4. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
Thukral DK; Dumoga S; Mishra AK
Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.
Suresh G; Manjunath K; Venkateswarlu V; Satyanarayana V
AAPS PharmSciTech; 2007 Mar; 8(1):24. PubMed ID: 17408223
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based colloidal carriers for peptide and protein delivery--liposomes versus lipid nanoparticles.
Martins S; Sarmento B; Ferreira DC; Souto EB
Int J Nanomedicine; 2007; 2(4):595-607. PubMed ID: 18203427
[TBL] [Abstract][Full Text] [Related]
8. Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
Gonçalves LM; Maestrelli F; Di Cesare Mannelli L; Ghelardini C; Almeida AJ; Mura P
Eur J Pharm Biopharm; 2016 May; 102():41-50. PubMed ID: 26925503
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and patents on solid lipid nanoparticles.
Sawant KK; Dodiya SS
Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of polymyxin-loaded solid lipid nanoparticles (PLX-SLN): Characterization of physicochemical properties and in vitro efficacy.
Severino P; Silveira EF; Loureiro K; Chaud MV; Antonini D; Lancellotti M; Sarmento VH; da Silva CF; Santana MHA; Souto EB
Eur J Pharm Sci; 2017 Aug; 106():177-184. PubMed ID: 28576561
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles: a versatile approach for controlled release and targeted drug delivery.
Munir M; Zaman M; Waqar MA; Khan MA; Alvi MN
J Liposome Res; 2024 Jun; 34(2):335-348. PubMed ID: 37840238
[TBL] [Abstract][Full Text] [Related]
12. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
[TBL] [Abstract][Full Text] [Related]
13. Physical chemical considerations of lipid-based oral drug delivery--solid lipid nanoparticles.
Bummer PM
Crit Rev Ther Drug Carrier Syst; 2004; 21(1):1-20. PubMed ID: 15099183
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems.
Priano L; Esposti D; Esposti R; Castagna G; De Medici C; Fraschini F; Gasco MR; Mauro A
J Nanosci Nanotechnol; 2007 Oct; 7(10):3596-601. PubMed ID: 18330178
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
Shidhaye SS; Vaidya R; Sutar S; Patwardhan A; Kadam VJ
Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems.
Uner M
Pharmazie; 2006 May; 61(5):375-86. PubMed ID: 16724531
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
Müller RH; Mäder K; Gohla S
Eur J Pharm Biopharm; 2000 Jul; 50(1):161-77. PubMed ID: 10840199
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
zur Mühlen A; Schwarz C; Mehnert W
Eur J Pharm Biopharm; 1998 Mar; 45(2):149-55. PubMed ID: 9704911
[TBL] [Abstract][Full Text] [Related]
19. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
20. Functionalized gold nanoparticles for drug delivery.
Han G; Ghosh P; Rotello VM
Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
